Načítá se...
Perfusion-Phase [(18)F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration
We aimed to test if early, perfusion phase tau-PET imaging with [(18)F]THK5351 might substitute for [(18)F]FDG PET information on neurodegeneration, as has been previously shown for amyloid-tracers. A patient with cognitive impairment and positive amyloid-PET was examined by [(18)F]THK5351 tau-PET a...
Uloženo v:
| Vydáno v: | J Alzheimers Dis Rep |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
IOS Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6159627/ https://ncbi.nlm.nih.gov/pubmed/30480233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/ADR-170023 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|